BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38849857)

  • 1. POEMS syndrome with undetectable M-protein: a case report and literature review.
    Xue HY; Zhou L; Yuan QZ; Zhang Y; Hao YQ; Chen SW; Wang HK; Wei F
    Diagn Pathol; 2024 Jun; 19(1):74. PubMed ID: 38849857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leave It to the Prose: A Case of POEMS Syndrome.
    Samant S; Umpierrez De Reguerro A
    Cureus; 2021 Oct; 13(10):e18664. PubMed ID: 34790444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis revealing POEMS syndrome. About a case.
    Dumas C; Bienvenu FH; Hicks J; Weber E; Sève P
    Ann Biol Clin (Paris); 2020 Apr; 78(2):195-197. PubMed ID: 32162605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
    Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
    Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
    Front Immunol; 2021; 12():681360. PubMed ID: 34025681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.
    Li Q; Xu F; Duan JF; Tang YF
    Medicine (Baltimore); 2020 Jul; 99(27):e20812. PubMed ID: 32629667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature.
    Pulivarthi S; Gurram MK
    J Cancer Res Ther; 2018; 14(3):679-681. PubMed ID: 29893339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
    Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
    Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [POEMS syndrome: Diagnosis, stratification, treatments].
    Talbot A; Jaccard A; Arnulf B
    Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
    Miralles GD; O'Fallon JR; Talley NJ
    N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
    Al-Mayoof O; Al Sughaiyer H; Abuomar W; Khan M
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28637843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POEMS syndrome: update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
    Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
    Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
    Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
    Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POEMS Syndrome: Therapeutic Options.
    Jaccard A
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [POEMS syndrome. An interdisciplinary clinical challenge].
    Braun SA; Albrecht P; Methner A; Hanneken S
    Hautarzt; 2011 Oct; 62(10):722-5. PubMed ID: 21915731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
    Hattori Y; Taguchi J; Imai N; Wasano K; Matsuura S; Koharazawa H; Ishigatsubo Y; Fujisawa S
    Rinsho Ketsueki; 2011 Apr; 52(4):219-22. PubMed ID: 21566409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.